Physician profile
Peter Wilkinson
NPI 1114675717
$3,046.23
in general payments reported to CMS, 2019-2025
9 companies · $2,573 in 2025
The $2,573 reported for 2025 was more than what 98% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.61 · 2023: $387 · 2024: $52.66 · 2025: $2,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945 · Travel and Lodging: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.84 |
| Travel and Lodging | $1,067.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,421.19 | 2022-2025 | Na, Vsp System, Vsp Cranial, Smartlock |
| Straumann USA LLC | $654.01 | 2025 | |
| Zimvie INC. | $235.09 | 2023-2025 | |
| Solventum Corporation | $171.43 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Axogen | $169.89 | 2025 | |
| Kerecis Limited | $123.85 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pacira Pharmaceuticals Incorporated | $120.38 | 2023 | Exparel |
| Alafair Biosciences, INC. | $120.08 | 2025 | Versawrap |
| Acera Surgical, INC. | $30.31 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.